去细胞化
戒毒(替代医学)
生物人工肝装置
肾
人工肾
医学
移植
肝移植
生物
重症监护医学
生物信息学
病理
组织工程
外科
生物医学工程
内科学
肝细胞
体外
替代医学
生物化学
作者
Cécile Legallais,DooLi Kim,Sylvia Mihaila,Milos Mihajlovic,Marina Figliuzzi,Barbara Bonandrini,Simona Salerno,Fjodor Yousef Yengej,Maarten B. Rookmaaker,Natalia Sánchez Romero,Pilar Sainz‐Arnal,Ulysse Pereira,Mattia Pasqua,Karin G. F. Gerritsen,Marianne C. Verhaar,Andrea Remuzzi,Pedro M. Baptista,Loredana De Bartolo,Rosalinde Masereeuw,Dimitrios Stamatialis
标识
DOI:10.1002/adhm.201800430
摘要
For patients with severe kidney or liver failure the best solution is currently organ transplantation. However, not all patients are eligible for transplantation and due to limited organ availability, most patients are currently treated with therapies using artificial kidney and artificial liver devices. These therapies, despite their relative success in preserving the patients' life, have important limitations since they can only replace part of the natural kidney or liver functions. As blood detoxification (and other functions) in these highly perfused organs is achieved by specialized cells, it seems relevant to review the approaches leading to bioengineered organs fulfilling most of the native organ functions. There, the culture of cells of specific phenotypes on adapted scaffolds that can be perfused takes place. In this review paper, first the functions of kidney and liver organs are briefly described. Then artificial kidney/liver devices, bioartificial kidney devices, and bioartificial liver devices are focused on, as well as biohybrid constructs obtained by decellularization and recellularization of animal organs. For all organs, a thorough overview of the literature is given and the perspectives for their application in the clinic are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI